Breaking News, Promotions & Moves

CavoGene Appoints CEO

Scott J. Fisher, PhD has previously led drug development and gene therapy clinical research of multiple regenerative therapies at early stage companies

CavoGene LifeSciences announced the appointment of Scott J. Fisher, PhD as chief executive officer.    Dr. Fisher is a regenerative medicine expert who has previously led drug development and gene therapy clinical research of multiple regenerative therapies at early stage companies. CavoGene will be headquartered at the Global Center for Heath Innovation in Cleveland, Ohio.  Cavogene has licensed a novel investigational gene therapy for patients with neurodegenerative diseases, su...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters